Autoimmune hepatitis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of Autoimmune hepatitis is approximately 1 to 2 per 100,000 individuals worldwide.<ref name="pmid18609163">{{cite journal |vauthors=Werner M, Prytz H, Ohlsson B, Almer S, Björnsson E, Bergquist A, Wallerstedt S, Sandberg-Gertzén H, Hultcrantz R, Sangfelt P, Weiland O, Danielsson A |title=Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study |journal=Scand. J. Gastroenterol. |volume=43 |issue=10 |pages=1232–40 |year=2008 |pmid=18609163 |doi=10.1080/00365520802130183 |url=}}</ref> | *The incidence of Autoimmune hepatitis is approximately 1 to 2 per 100,000 individuals worldwide.<ref name="pmid18609163">{{cite journal |vauthors=Werner M, Prytz H, Ohlsson B, Almer S, Björnsson E, Bergquist A, Wallerstedt S, Sandberg-Gertzén H, Hultcrantz R, Sangfelt P, Weiland O, Danielsson A |title=Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study |journal=Scand. J. Gastroenterol. |volume=43 |issue=10 |pages=1232–40 |year=2008 |pmid=18609163 |doi=10.1080/00365520802130183 |url=}}</ref><ref name="pmid9489916">{{cite journal |vauthors=Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H |title=Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population |journal=Scand. J. Gastroenterol. |volume=33 |issue=1 |pages=99–103 |year=1998 |pmid=9489916 |doi= |url=}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
Revision as of 14:46, 6 December 2017
|
Autoimmune hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autoimmune hepatitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Autoimmune hepatitis epidemiology and demographics |
|
Autoimmune hepatitis epidemiology and demographics in the news |
|
Risk calculators and risk factors for Autoimmune hepatitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Manpreet Kaur, MD [2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of Autoimmune hepatitis is approximately 1 to 2 per 100,000 individuals worldwide.[1][2]
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Werner M, Prytz H, Ohlsson B, Almer S, Björnsson E, Bergquist A, Wallerstedt S, Sandberg-Gertzén H, Hultcrantz R, Sangfelt P, Weiland O, Danielsson A (2008). "Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study". Scand. J. Gastroenterol. 43 (10): 1232–40. doi:10.1080/00365520802130183. PMID 18609163.
- ↑ Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H (1998). "Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population". Scand. J. Gastroenterol. 33 (1): 99–103. PMID 9489916.